• 5274 Citations
  • 39 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Area of Expertise

The O’Bryant laboratory is dedicated to precision medicine in Alzheimer’s disease and other neurodegenerative diseases, including Down syndrome, Lewy Body disease, Parkinson’s disease, traumatic brain injury, and others. The fully translational lab has a Biomarker Core (Dr. Hall, Director), Clinical Core (Dr. Johnson, Director), Administrative Core (Dr. O’Bryant, Director) and Data Core (Dr. Johnson, Director). The lab also has a Neuroimaging Core (USC, Dr. Toga, Director). Dr. O’Bryant's multiple NIH grants focus on novel strategies for disease detection, screening into trials (therapeutic and prevention), and patient stratification for optimal treatment response. As part of this work, the lab has a strong focus on the impact of ethnicity/diversity on cognitive loss during the aging process and runs the one-of-a-kind Health & Aging Brain among Latino Elders (HABLE) study, which is the most comprehensive study of Mexican-American brain aging to date.

Education/Academic qualification

BS in Psychology, Louisiana State University

MA in Clinical Psychology, University at Albany

PhD in Clinical Psychology, University at Albany

Fingerprint Dive into the research topics where Sid O'Bryant is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Open Access
  • Cognition and the Predictive Utility of Three Risk Scores in an Ethnically Diverse Sample

    Torres, S., Alexander, A., O'Bryant, S. & Medina, L. D., 1 Jan 2020, In : Journal of Alzheimer's disease : JAD. 75, 3, p. 1049-1059 11 p.

    Research output: Contribution to journalArticle

  • Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study

    The Alzheimer’s Disease Genetics Consortium, 1 Dec 2020, In : Nature Communications. 11, 1, 667.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Scopus citations

    Factores de riesgo cardiovascular en Estados Unidos y México: Comparación de los estudios hable y enasem

    Translated title of the contribution: Cardiovascular risk factors in Mexico and the United States: A comparative cross-sectional study between the hable and MHAS participantsVintimilla, R., Reyes, M., Johnson, L., Hall, J. & O’bryant, S., 1 Jan 2020, In : Gaceta medica de Mexico. 156, 1, p. 16-20 5 p.

    Research output: Contribution to journalArticle

    Open Access